Teeple, A., & Muser, E. (2017). Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 1(3.1), s6. https://doi.org/10.25251/skin.1.supp.5